You are here

  • Home
  • Archive
  • Volume 71, Issue 3
  • The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

Citation Tools

Article menu
Download PDFPDF
Basic and translational research
Extended report
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rosengren S, Corr M, Firestein GS, et al
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon
Annals of the Rheumatic Diseases 2012;71:440-447.